Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cells.

International journal of oncology

Volumn 26, Issue 6, 2005, Pages 1569-1574

  Louis, Monette ^a   Rosato, Roberto R ^a   Battaglia, Eric ^a   Néguesque, Adrien ^a   Lapotre, Agnès ^a   Grant, Steven ^a   Bagrel, Denyse ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE; DOXORUBICIN; ENZYME INHIBITOR; GLUTATHIONE; HISTONE DEACETYLASE; VERAPAMIL; VINCRISTINE;

ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; DRUG POTENTIATION; FEMALE; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; BUTYRATES; CELL LINE, TUMOR; DOXORUBICIN; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; GLUTATHIONE; HISTONE DEACETYLASES; HUMANS; VERAPAMIL; VINCRISTINE;

MLCS; MLOWN;

EID: 22344444291     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.26.6.1569     Document Type: Article

References (0)